
    
      The use of medications in adolescents and young adults with ASD is extremely common. few data
      address the effectiveness and harms of medications specifically in this population. A
      previous study reported the first case study demonstrating clinical improvement in mood and
      eye fixation scores from intranasal ketamine treatment in a "complicated" subject with autism
      spectrum disorderHowever,The purpose of the study is to determine the efficacy and safety of
      intranasal ketamine with dexmedetomidine in children with ASD.
    
  